Thursday 22 August 2024

• 09:30 - First-in-class inhibitors of ERAP1 generate novel targets for MHC-I-directed therapies
  Dr. Wayne Paes (Grey Wolf Therapeutics)
  CAMS Oxford Institute Seminars